Global Artificial Insemination Market

Artificial Insemination Market Size, Share, Growth Analysis, By Type (Intrauterine, Intravaginal), By Source Type (AIH-Husband, AID-Donor), By End Use (Fertility Clinics, Other Facilities), By Region -Industry Forecast 2024-2031.

Report ID: SQMIG35A2961 | Region: Global | Published Date: November, 2024
Pages: 159 | Tables: 87 | Figures: 71

Artificial Insemination Market Competitive Landscape

The report involves an in-depth study of the competitive environment surrounding the global artificial insemination market. The competition analysis included within the study covers market structure, market share by major players, player positioning, top winning strategies, competitive dashboard, and business assessment quadrant. It includes detailed profiles for all major companies.

Top Player’s Company Profiles

  • Conceivex Inc. 
  • FUJIFILM Irvine Scientific Inc. 
  • Genea Limited 
  • Genus plc 
  • Zoetis Inc. 
  • Inguran LLC 
  • ABS Global 
  • Hamilton Thorne Inc. 
  • Hi-Tech Solutions 
  • Kitazato Corporation 
  • Pride Angel 
  • Rinovum Women’s Health LLC 
  • Rocket Medical plc 
  • TenderNeeds Fertility LLC 
  • Vitrolife AB 
  • Imv Technologies 
  • Neogen Corporations 
  • Agtech inc 
  • Continental Genetics 
  • Select Series

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Artificial Insemination Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.2 billion in 2023 to USD 3.8 billion by 2031, growing at a CAGR of 8.01% during the forecast period (2024-2031).

The report involves an in-depth study of the competitive environment surrounding the global artificial insemination market. The competition analysis included within the study covers market structure, market share by major players, player positioning, top winning strategies, competitive dashboard, and business assessment quadrant. It includes detailed profiles for all major companies. 'Conceivex Inc. ', 'FUJIFILM Irvine Scientific Inc. ', 'Genea Limited ', 'Genus plc ', 'Zoetis Inc. ', 'Inguran LLC ', 'ABS Global ', 'Hamilton Thorne Inc. ', 'Hi-Tech Solutions ', 'Kitazato Corporation ', 'Pride Angel ', 'Rinovum Women’s Health LLC ', 'Rocket Medical plc ', 'TenderNeeds Fertility LLC ', 'Vitrolife AB ', 'Imv Technologies ', 'Neogen Corporations ', 'Agtech inc ', 'Continental Genetics ', 'Select Series'

Going up is the infertility rates across the globe, which is working as an imperative for the artificial insemination market. Artificial insemination, to a large extent, has become a necessity of the day because of delayed conception, changing lifestyles, environmental issues, and the growing disorders related to the reproductive organ. Only assisted reproductive technology can provide solutions to couples and individuals not able to conceive naturally. These challenges can be overcome with artificial insemination, which will contribute to better adoption of the procedure. Moreover, increased awareness and acceptability of fertility treatments, along with a greater interest from more people in such advanced methods for their reproductive goals, encourage the market.

Increasing Utilization of Advanced Reproductive Technologies: Artificial insemination treatment combines less invasive techniques with advanced reproductive technology to maximize the conception rate. Included in these are advanced techniques in genetic screening and cryopreservation, high-tech sperm treatment and processing techniques, and many others. One such instance includes preimplantation genetic testing, which is the genetic scanning of embryos before implantation to eliminate the possibility of a genetic disorder in the child. Moreover, patients are given more options and leeway because of advancements in the areas of sperm freezing and thawing. The rationale behind the technological advances is to extend growth and expansion into the market by having better, more personalized treatment procedures and higher success rates for artificial insemination operations.

A severe decline in fertility rates across the continent witnessed Europe emerge as the biggest regional market. The decline is blamed on a change in cultural norms, different priorities, and late pregnancies on account of professional and lifestyle reasons. This, in turn, has created a growing demand for better fertility treatments as many European countries wrestle with decreasing birth rates to help people and couples attain their reproductive goals. There is, therefore, a significant market in fertility services and solutions that aim to reverse the trends or at least encourage family planning through advanced therapies and technologies due to the continued decline in birth rates.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Artificial Insemination Market

Report ID: SQMIG35A2961

$5,300
BUY NOW GET FREE SAMPLE